Set up patient and equipment
1. Interview (screen) the patient to ensure that he/she has no contraindication for MR scanning such as cardiac pacemaker or other implants containing ferromagnetic materials. Also be sure to find out if the patient has any health conditions that may require the presence of special emergency equipment during the scanning procedure, or that necessitate other special precautions. Screening forms are often employed for all patients before scanning in an MRI system.
Generally standard screening forms are used for all patients scanned in a magnetic resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact composition of the items, it is best to exclude patients with any metal implants; see Shellock (1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can sit in the room during the scan and comfort the patient as needed. This companion must be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal that might be found in clothing.
4. Have the patient remove any mascara or other metal-containing makeup to avoid local tissue heating and image artifacts.
5. Inform the patient about what will occur during the procedure, what he/she will experience while in the magnet, and how to behave, to include the following:
a. If earphones/headphones are used to protect the ears from loud sounds produced by the scanner, the patient will be asked to wear these, but will be able to communicate with the technologist at any/all times during the procedure. b. The patient will be given a safety squeeze-bulb or similar equipment to request assistance at any time (demonstrate how this equipment works). c. For optimum results the patient should not talk, and should avoid/minimize swallowing or other movement during each scan-i.e., as long as the banging sounds continue. Between scans, talking and swallowing are allowed in most cases, but should be avoided when comparative positional studies are being performed. The patient will be informed in these instances. d. Nevertheless, the patient may call out at any time if he/she feels it necessary.
6. Have the patient lay supine on the scanner table. Either before or directly after the patient is positioned on the table, set up any triggering devices or other necessary monitoring equipment.
7. Establish an i.v. line through which the contrast agent can be injected, and attach this line securely to the patient so that movement into or out of the magnet will not pull at the patient's arm.
It is preferable to insert the line prior to imaging. This allows no intervening motion between those scans performed before and those run after the contrast agent injection.
10. Use the centering light to position the patient and place them into the center of the magnet. The nasion is the landmark and utilized here. Sequence 2: T 1 -sagittal head 13. This sequence serves as a true T 1 -weighted sagittal study of the head. Bring the sequence for a sagittal T 1 -weighted scan up onto the console and utilize the parameters in Table A4.1.3. 14. Use the pilot sequence to set up the scan levels.
15. Let the patient know you are ready, and begin the scan. Sequence 3: T 1 -transverse head 16. Bring the sequence for a transverse T 1 -weighted scan up onto the console. Set the imaging parameters as shown in Table A4 . 1.4. 17 . Use the pilot sequence to set up the scan levels.
18. Let the patient know you are ready, and begin the scan. 23. Use the pilot sequence to set up the scan levels.
24. Let the patient know you are ready, and begin the scan.
Sequence 6: T 1 -transverse post-gadolinium head 25. Bring the sequence for a transverse T 1 -weighted scan up onto the console. Set the imaging parameters as shown in Table A4 . 1.7. 26. Use the pilot sequence to set up the scan levels.
27. Leaving the patient in the magnet, inject the contrast agent either by hand, or using a mechanical injector. Observe the injection to insure there is no extravasation of the contrast agent. Flush the line with 10 ml of sterile normal saline. Begin the scan as soon as the injection is completed.
Alternatively, the scanning 
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This is essentially the same sequence as the pre-gadolinium scan, but can be performed with the addition of a flow compensation (FC) pulse to better delineate the cerebral vessels, and a magnetization transfer (MT) pulse to optimize enhancing lesion detection.
Sequence 7: T 1 -coronal post-gadolinium head 28. Bring the sequence for a T 1 -weighted scan up onto the console. Set the imaging parameters as shown in Table A4 .1.8.
29
. Use the pilot sequence to set up the scan levels.
30. Let the patient know you are ready, and begin the scan. 
SPECIAL SITUATIONS
The two sequences that follow are presented here for consideration by the radiologist in those patients suspected of significant intracranial inflammatory conditions for whom the basic protocol has failed to elucidate a clearly defined abnormality. For instance, in patients with microabscesses related to septic emboli that may be associated with pseudoaneurysm formation, the gradient-echo sequence is extremely useful for demon- 
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Infectious Diseases of the Brain strating the microhemorrhage. This can lead not only to the helpful diagnostic clue of a hemorrhagic lesion but also can bring other lesions to the attention of the radiologist. This can impact patient prognosis, or guide more effective follow-up imaging. The second optional sequence, the 3-dimensional gradient-echo post-contrast sequence, is usually reserved for higher resolution of small lesions or adjacent structures that may be affected by the pathology. It can also be an effective aid in operative planning, and may indeed serve as the base MRI sequence for several of the commercially available image-guided surgery tools presently on the market and utilized by many neurosurgeons. This sequence can be utilized in lieu of the transverse and coronal post-gadolinium sequences outlined in the Basic Protocol, if desired. It is easily manipulated in post-processing to yield a desired projection of a lesion, or simply to give a multiplanar assessment of the brain in a given patient.
Set up patient and equipment 1. Use the same equipment and the same patient set-up as for the previous method (see Basic Protocol, steps 1 to step 11).
2. Run the pilot scan as sequence 1 in the Basic Protocol (see Table A4 .1.2).
Sequence 8: Coronal gradient echo (head) 3. Bring the sequence for a gradient-echo scan up onto the console. Set the imaging parameters as shown in Table A4 .1.9.
4. Use the pilot sequence to set up the scan levels.
5. Let the patient know you are ready, and begin the scan. 7. Perform scan with high resolution parameters as described in 8. Perform planar reformations of the 3-D data set on-line or off-line using the reformation software.
One can coordinate with the neurosurgeon to obtain the most useful projections, that can then be saved and/or filmed.
Note that the cerebral vasculature is quite bright on this sequence as this 3-D gradient echo sequence is the base-sequence for time-of-flight (TOF) magnetic resonance angiography (MRA).
ALTERNATE PROTOCOL 2
IMAGING OF CEREBRAL ABSCESS BY MAGNETIC RESONANCE DIFFUSION, PERFUSION, AND SPECTROSCOPY
The Basic Protocol is quite sufficient in most instances of cerebral abscess imaging and represents the standard for imaging of the patient suspected for cerebral abscess. However, in certain clinical instances there may remain confusion as to the diagnosis, or in order to gain a higher degree of specificity in labeling a lesion as an abscess, further imaging (Ernst et al., 1998; Burtscher and Holtas, 1999; Desprechins et al., 1999) has indicated a clinical benefit in some patients with these new approaches. Higher-field-strength magnets with enhanced gradient packages (e.g., generally >20 mT/m for dMRI and pMRI) are preferred for optimum benefit in the performance of these sequences. Also, magnetic field homogeneity is a crucial factor in the successful performance of these sequences, mandating routine assessment and optimization of magnet shim prior to each acquisition. Indeed, as the hardware and software to obtain these specialized sequences becomes more ubiquitous and further data is gathered, one or more of these sequences may prove invaluable in the work-up of the patient suspected of cerebral abscess. Described here is the authors' experience with a 1.5 T whole-body system with an enhanced gradient system. Note that a detailed presentation on the performance and processing of these complex sequences goes beyond the scope of this unit. For such a discussion, the reader is referred to their respective scanner and workstation manufacturers, as well as the literature cited in this unit. Additionally, having an MRI-trained physicist available to insure the proper quality management of these sequences is highly recommended.
Additional Materials
Enhanced gradient equipped MRI scanner Specialized post-processing software, especially for pMRI image processing (a separate workstation is preferred for off-line processing of data sets, enabling continuous patient scanning to proceed) Power injector for dynamic contrast administration (i.e., while scanning)
Set up patient and equipment 1. Perform the patient setup as for the previous method (see Basic Protocol, steps 1 to 11).
2. Run sequence 1 as in Basic Protocol (see Table A4 .
1.2).
Sequence 10: pMRI of the brain 3. Perform this scanutilizing the parameters outlined in 
This sequence must be the first sequence performed after the gadolinium injection, and is acquired dynamically. After a baseline brain image acquisition is performed, an injection time of <8 sec is used to deliver 0.2 mmol/kg gadolinium chelate with a 10 ml normal saline bolus flush via the injector. This step may be performed by hand, but timing of the sequence is problematic.
4. Perform image analysis visually or off-line on a workstation using commercially available programs.
Regional cerebral blood volume (rCBV) maps can be reconstructed using an appropriate analysis of the MR signal intensity as a function of time.
The rCBV maps can be aligned with the anatomic images to obtain region-of-interest (ROI) data.
Sequence 11: Echo-planar imaging (EPI) dMRI of the brain 5. Run this sequence utilizing the parameters outlined in Table A4 .1.12 to assess water motion within the brain parenchyma. 
Diffusion imaging may help in the differential diagnosis of cerebral abscess versus necrotic neoplasm.
These data provide raw diffusion-weighted multishot echo-planar images and is used to process apparent diffusion coefficient (ADC) maps.
Sequence 12: MRS of the brain 7. Use previously acquired multiplanar sequences to place the single voxel over a region of interest. The voxel is 2 × 2 × 2 cm 3 and should be located in the brain, avoiding contamination of signal and magnetic field inhomogeneities from cerebrospinal fluid, fat, bone, and air (sinuses).
To assume the proper voxel placement, it is recommended that its position be checked in three planes prior to running the sequence.
8. Before the sequence can be run, two important steps must be completed: shimming over the voxel and water suppression. Many scanners have automated packages to perform these functions. However, these preliminary steps may take 5 min to perform.
9. Run this sequence utilizing the parameters outlined in Table A4 .1.14 to provide information as to the specific molecular substrate within a volume of interest that can indicate the presence of abnormal tissue or metabolic processes.
MRS can be used in the diagnosis and follow-up of cerebral abscesses.
10. Sequence acquisition time is 10 min per T E performed (including the water suppression and shimming, with the sequence acquisition), making useful results difficult to obtain in agitated patients. 
COMMENTARY Background Information
Cerebritis and abscess, though not common diagnoses, remain disturbingly common today despite the advent of, and significant advances in, the field of microbiology. This is primarily related to the increased prevalence of immunocompromised patient populations and resistant strains of microorganisms. The patient with cerebral abscess may present in a nonspecific fashion. The most commonly noted symptom is headache, which may be the only complaint. More disturbing signs and symptoms of fever (i.e., <50% in some series), altered sensorium, focal neurologic deficit, and seizure may also manifest. The primary source of the intracranial infection may be an important clue and should be sought.
MR has emerged as the study of choice in patients suspected of harboring a cerebral abscess(es), primarily as it is significantly more sensitive for the detection of inflammatory disease in the central nervous system (CNS) than computed tomography (CT) and the other imaging and laboratory studies (Mathisen and Johnson, 1997) . The results of the Basic Protocol outlined above are often nonspecific though, yielding a differential diagnosis that also includes primary and metastatic brain tumors, resolving hematoma, infarction, and demyelinating disease. However, MR is crucial for defining not only the presence of disease, but also the extent, and is used in surgical planning (and timing) with these patients. With the recent advancements of diffusion, perfusion, and spectroscopic sequences, and newly available research data, the lack of specificity of the technique is rapidly diminishing. pMRI parallels the published results of nuclear medicine studies differentiating abscess from neoplasm using single-photon emission CT (SPECT) and positron emission tomography (PET; Ernst et al., 1998) . However, pMRI is a more convenient and rapid exam (when performed in conjunction with the MR study). In addition, the anatomic information and higher spatial resolution provided by MRI make the technique a powerful tool in these patients. Additionally, MR can be used to follow cerebral abscess patients through their therapy. Not only does MR demonstrate reduced size and number of lesions and mass effect with effective therapy, but also the status of organism activity within abscesses and their response to antibiotics may be assessed (Burtscher and Holtas, 1999 ). This in turn may lead to earlier intervention with percutaneous or surgical drainage of abscess cavities or more rapid assignment of the proper differential diagnosis of a noninfectious lesion, such as tumor, allowing for directed therapies to be instituted. The sensitive detection and proper classification of infectious lesions and abscess by MR can also provide more timely and directed determination of the source of an infection, with institution of the necessary treatments, as is seen with cardiac valvular disease causing mycotic aneurysm and abscess. Laboratory analysis is still required to determine the specific infectious organism.
Critical Parameters and Troubleshooting
There are several parameters that enhance the sensitivity and utility of the Basic Protocol (Orrison et al., 1995) . These include the proper selection of the T I (inversion time) for the FLAIR images to effect nulling of hyperintense cerebrospinal fluid (CSF) signal, producing dark CSF. This enables the detection of abnormal periventricular high T 2 -signal intensity for the important determination of ventriculitis/ependymitis, indicating spread of infection to the ventricles or possibly rupture of the abscess into the CSF spaces. Interestingly, most patients have a thin rim of this hyperintensity in the normal state. Additionally, the use of the MT pulse for the post-gadolinium sequences improves the sensitivity for early detection of subtle foci of abnormal enhancement. The MT pulse works by suppressing overall background signal intensity, thus leaving the high T 1 -signal of enhancing tissue more apparent. When considering the optional sequences, the optimal choice of T E on the gradient-echo coronal sequence is important to allow for detection of foci of microhemorrhage. These foci may indicate the presence of satellite lesions of infection, and their detection may narrow the differential diagnostic possibilities for infectious organism (such as Herpes simplex virus, 
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which is angioinvasive and thus predisposed to causing hemorrhage). A longer T E will demonstrate increased T 2 -based contrast and magnetic susceptibility with more pronounced low signal "blooming" from foci of hemorrhage containing hemosiderin (Fig. A4.1.1 ), though at the expense of overall tissue signal-to-noise ratio (SNR). Generally, T E values of <25 msec (the authors use 24.6 msec) are less sensitive for this purpose. For similar reasons, this "blooming" is prominent from densely calcified cortex, such as in the calvarium, and makes for poor evaluation of signal at the skull-brain interface, particularly at the skull base.
An option with speed and utility that can be performed in place of both the gradient-echo coronal and FLAIR/FSE T 2 transverse sequences is a standard proton-density/T 2 dualecho spin-echo sequence (see UNIT A5.1). For a time expenditure similar to that of the Basic Protocol, the sensitivity for magnetic susceptibility (better on T 2 spin-echo than FSE, but best on the gradient-echo coronal sequence) is improved, but at the expense of some sensitivity in the detection of periventricular disease (better with the FLAIR). Also, if detection of brain calcifications is important, this is still best accomplished with CT, as the gradient-echo coronal sequence, though quite sensitive for the magnetic susceptibility of calcified foci, is nonspecific in differentiating calcium from blood products. Additional time savings for imaging critically ill or noncompliant patients can be found by limiting pre-contrast and post-contrast T 1 -weighted sequences to one plane each, or performing only one acquisition (N acq ) on each sequence, or alternatively by utilizing FSE T 1 -weighted sequences rather than routine T 1 -weighted sequences. These maneuvers will all limit SNR and sensitivity for detection of abnormal contrast enhancement, but will afford faster protocol scan times (for a more detailed discussion of fast-scan techniques, see chapter A5 of this series).
Anticipated Results
Brain abscesses have been shown to progress through four evolutionary stages on imaging studies, with the first being the acute or cerebritis stage (Taveras and Pile-Spellman, 
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1996; Wong and Quint, 1999) . This occurs during the first 5 days of the infection and is characterized by a loss of the blood-brain-barrier integrity with edema formation and (rarely) microhemorrhage. Imaging is characteristically normal on CT, though either CT or MR may demonstrate edema without prominent mass effect or contrast enhancement. The late cerebritis stage begins at the end of the first week and is characterized by progression to necrosis with a thin rim of granulation tissue. Imaging will show increased edema and mass effect and minimal, diffuse enhancement. Satellite lesions may emerge (Fig. A4.1.2) . Any extension of the process is usually noted within the white matter, and it is in this second stage that rupture into the ventricular system is most likely. By the end of the second week (capsular stage) a capsule can be defined on imaging studies that thickens over time, especially along the more superficial (i.e., gray matter) border. The capsule is now considered complete, with three definable layers: inner granulation layer, middle collagenous layer, and outer gliotic layer. Imaging will show this well defined and prominently enhancing capsule encompassing the liquefied abscess with decreased surrounding edema. Surgery is often delayed until this stage to allow for greater success in lesion resection and to minimize hemorrhage in adjacent structures. Finally, in the chronic stage, abscesses most often continue to grow, eventually resulting in a significant morbid event such as rupture into the ventricular or subarachnoid CSF. However, growth arrest and mineralization of the capsule may occur, as can resolution and resorption, especially with successful antibiotic therapy. Imaging will parallel these changes with continued enhancement of the capsule, while resorbing lesions may lose their necrotic center, eventually becoming small foci of enhancement or mineralization.
At initial presentation, the typical cerebral abscess appears on MR imaging as a well-defined rounded lesion with fluid-signal material centrally and a rim of thin, uniform low signal intensity on T 2 -weighted images that demonstrates smooth, homogeneous enhancement (Fig. A4.1.3 ). This is usually surrounded by a variable amount of parenchymal edema. The lesion is most commonly located in the frontal lobe (adjacent an infected sinus, usually the frontal), the parietal lobe (reflecting hematogenous spread from the infection source, and centering at the gray-white junction), or less commonly in the temporal lobe adjacent an infected temporal bone. On pMRI, a cerebral abscess is expected to demonstrate decreased perfusion relative to normal brain, and markedly decreased perfusion relative to hypervascular tumors that generally show increased perfusion (Ernst et al., 1998) . On dMRI, cerebral abscess will typically demonstrate high signal on diffusion-weighted images, with markedly decreased abscess cavity signal on ADC images (Desprechins et al., 1999) . This is the opposite of that found in necrotic tumors such as glioblastoma multiforme (Fig. A4.1.4) . And finally, MRS tracings may show specific products of infectious organism metabolism (i.e., acetate, lactate, pyruvate and succinate-metabolites not reported in human brain tissue other than in infectious states) in the acute/pretreatment phase, with regression over the course of therapy to a single lactate peak of a "dead" abscess, indicating the cessation of viable infectious organism activity (Burtscher and Holtas, 1999) . Also, the presence of a group of resonances at 0.9 ppm on the T E = 270 msec sequence demonstrating inversion on a 135 msec sequence is diagnostic (95% specific) of bacterial abscess. Several amino acids, including valine, leucine and isoleucine, produce this peak and are found in pus within bacterial abscesses at concentrations 20 to 80 times greater than that found in necrotic tumor cavities. Unfortunately, this relationship is not found in abscesses caused by non-bacterial organisms (Grand et al., 1999) .
